Torrent Pharmaceuticals Ltd. discloses a USFDA inspection conclusion for its Bileshwarpura oncology facility under SEBI LODR Reg. 30.
The USFDA inspection was conducted from 6th April 2026 to 10th April 2026.
The inspection concluded with zero observations, indicating no regulatory compliance issues were identified.